Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-10-05

Teladoc Health (TDOC)

CEO Charles Divita, III was paid $11,202,996 in fiscal year 2025, ↓ down 30.2% from fiscal year 2024, the 44th percentile of its disclosed peer group (SEC filing 0001477449-26-000020 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$11,202,996 ↓
Charles Divita, III total, FY2025
44th
CEO pay percentile vs peers
127.6:1
CEO-to-median pay ratio
88.8%
Say-on-pay support, latest vote

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

TDOC's next annual pay disclosure, estimated April 6, 2027.est. Filing ↗

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Charles Divita, III$800,000$0$9,699,996$0$584,000$0$119,000$11,202,996
Chief Executive Officer
Mala Murthy489,37503,299,99800014,0003,803,373
Former Chief Financial Officer
Carlos Nueno589,55202,000,0000564,201095,3733,249,126
President, International
Kelly Bliss516,66702,099,9970331,500014,0002,962,164
President, U.S. Group Health
Adam Vandervoort495,00002,099,9970247,000014,0002,855,997
Chief Legal Officer and Secretary

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Charles Divita, III$11,202,996$16,061,267—↓ −4,858,271
Mala Murthy3,803,3735,230,694—↓ −1,427,321
Carlos Nueno3,249,1262,739,138—↑ +509,988
Kelly Bliss2,962,1642,514,739—↑ +447,425
Adam Vandervoort2,855,9972,634,319—↑ +221,678

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

You have just read Teladoc Health's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper TDOC reports.

We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.

How we handle your data → Privacy

Companies that benchmark against TDOC
15 companies name TDOC as a compensation peer

The list of companies that name TDOC as a peer is temporarily unavailable — recheck shortly.

01c

Board of directors

One page per director: the seat, the committees and the fee table, read for one person at a time.

DirectorRoleFY2025 total
Catherine A. JacobsonIndependent Director$260,003
David B. Snow, JrIndependent Director$284,014
David L. ShedlarzIndependent Director$272,503
J. Eric EvansIndependent Director$275,003
Kenneth H. PaulusChair of the Board$283,492
Mark Douglas Smith, M.D., MBAIndependent Director$260,003
Michael S. SmithIndependent Director—
Sandra L. FenwickIndependent Director$255,003
Susan R. SalkaIndependent Director—
Thomas G. McKinleyIndependent Director$262,503
02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
David B. Snow, JrDirector2026-05-20D28,986$0$0Derivative, Class A CommonForm 4 ↗
David B. Snow, JrDirector2026-05-20A28,986——CommonForm 4 ↗
Catherine A. JacobsonDirector2026-05-20D28,98600Derivative, Class A CommonForm 4 ↗
Catherine A. JacobsonDirector2026-05-20A28,986——CommonForm 4 ↗
David L. ShedlarzDirector2026-05-20D28,98600Derivative, Class A CommonForm 4 ↗
David L. ShedlarzDirector2026-05-20A29,986——CommonForm 4 ↗
David L. ShedlarzDirector2026-05-21A30,44100Derivative, Class A CommonForm 4 ↗
Sandra L. FenwickDirector2026-05-21A30,44100Derivative, Class A CommonForm 4 ↗
Kenneth H. PaulusDirector2026-05-21A30,44100Derivative, Class A CommonForm 4 ↗
David B. Snow, JrDirector2026-05-21A30,44100Derivative, Class A CommonForm 4 ↗
Catherine A. JacobsonDirector2026-05-21A30,44100Derivative, Class A CommonForm 4 ↗
Michael S. SmithDirector2026-05-21A30,44100Derivative, Class A CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-06-01A1,042——CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-06-01A9,152——CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-06-01A5,350——CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-06-01A426——CommonForm 4 ↗
Dividend-equivalent accruals2026-06-01—5,606——5 insiders, 6 accrual rows
Fernando M. RodriguesPresident of BetterHelp2026-06-01D5,49100Derivative, Class A CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-06-01D9,15200Derivative, Class A CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-06-01D4,85800Derivative, Class A CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-06-01A4,858——CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-06-01A1,300——CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-06-01A833——CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-06-01A39——CommonForm 4 ↗
Charles Divita, IIIDirector2026-06-01D42,27600Derivative, Class A CommonForm 4 ↗
Charles Divita, IIIDirector2026-06-01A42,276——CommonForm 4 ↗
Charles Divita, IIIDirector2026-06-01A1,966——CommonForm 4 ↗
Carlos NuenoPresident, International2026-06-01D8,71600Derivative, Class A CommonForm 4 ↗
Carlos NuenoPresident, International2026-06-01D4,55600Derivative, Class A CommonForm 4 ↗
Carlos NuenoPresident, International2026-06-01A8,716——CommonForm 4 ↗
Carlos NuenoPresident, International2026-06-01A4,556——CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-06-01D9,15200Derivative, Class A CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-06-01D5,35000Derivative, Class A CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-06-01A9,152——CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-06-01D8,71600Derivative, Class A CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-06-01A8,716——CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-06-01A5,491——CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-06-02D5,677843,298CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-06-02D7,679858,568CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-06-02D28482,166CommonForm 4 ↗
Charles Divita, IIIDirector2026-06-02D19,1328145,920CommonForm 4 ↗
Carlos NuenoPresident, International2026-06-02D6,196847,257CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-06-02D7,906860,299CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-06-03D9,572770,833CommonForm 4 ↗
Charles Divita, IIIDirector2026-06-10D39,16000Derivative, Class A CommonForm 4 ↗
Charles Divita, IIIDirector2026-06-10D3,64200Derivative, Class A CommonForm 4 ↗
Charles Divita, IIIDirector2026-06-10A39,160——CommonForm 4 ↗
Charles Divita, IIIDirector2026-06-10A3,642——CommonForm 4 ↗
Charles Divita, IIIDirector2026-06-11D18,0747125,470CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-06-29D2,500921,250CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-07-01D2,500922,500CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-07-01D2,08300Derivative, Class A CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-07-01A2,083——CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-07-02D65395,942CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-07-06D2,5001023,750CommonForm 4 ↗
Mark Anquillare VDirector2026-08-03A37,42500Derivative, Class A CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-09-01A5,350——CommonForm 4 ↗
Carlos NuenoPresident, International2026-09-01A4,556——CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-09-01D9,15200Derivative, Class A CommonForm 4 ↗
Carlos NuenoPresident, International2026-09-01D4,55600Derivative, Class A CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-09-01A8,717——CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-09-01A1,042——CommonForm 4 ↗
Dividend-equivalent accruals2026-09-01—5,606——5 insiders, 6 accrual rows
Charles Divita, IIIDirector2026-09-01A1,966——CommonForm 4 ↗
Charles Divita, IIIDirector2026-09-01A42,277——CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-09-01A39——CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-09-01A833——CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-09-01D9,15200Derivative, Class A CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-09-01D8,71700Derivative, Class A CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-09-01D5,49200Derivative, Class A CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-09-01A5,492——CommonForm 4 ↗
Charles Divita, IIIDirector2026-09-01D42,27700Derivative, Class A CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-09-01D4,85900Derivative, Class A CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-09-01A1,300——CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-09-01A9,152——CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-09-01A4,859——CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-09-01D5,35000Derivative, Class A CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-09-01A426——CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-09-01A9,152——CommonForm 4 ↗
Carlos NuenoPresident, International2026-09-01D8,71700Derivative, Class A CommonForm 4 ↗
Carlos NuenoPresident, International2026-09-01A8,717——CommonForm 4 ↗
Michael F. GrasherChief Financial Officer2026-09-01A239,61600Derivative, Class A CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-09-02D27461,726CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-09-02D5,439634,271CommonForm 4 ↗
Charles Divita, IIIDirector2026-09-02D18,3276115,478CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-09-02D7,357646,356CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-09-02D7,573647,717CommonForm 4 ↗
Carlos NuenoPresident, International2026-09-02D6,200639,066CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-09-03D9,812763,876CommonForm 4 ↗
Charles Divita, IIIDirector2026-09-10A3,642——CommonForm 4 ↗
Charles Divita, IIIDirector2026-09-10D39,16000Derivative, Class A CommonForm 4 ↗
Charles Divita, IIIDirector2026-09-10D3,64200Derivative, Class A CommonForm 4 ↗
Charles Divita, IIIDirector2026-09-10A39,160——CommonForm 4 ↗
Charles Divita, IIIDirector2026-09-11D17,8056108,682CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-10-01D2,08300Derivative, Class A CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-10-01A2,083——CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-10-02D65563,703CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

View all 107 transactions
InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
David B. Snow, JrDirector2026-05-20D28,986$0$0Derivative, Class A CommonForm 4 ↗
David B. Snow, JrDirector2026-05-20A28,986——CommonForm 4 ↗
Catherine A. JacobsonDirector2026-05-20D28,98600Derivative, Class A CommonForm 4 ↗
Catherine A. JacobsonDirector2026-05-20A28,986——CommonForm 4 ↗
David L. ShedlarzDirector2026-05-20D28,98600Derivative, Class A CommonForm 4 ↗
David L. ShedlarzDirector2026-05-20A29,986——CommonForm 4 ↗
David L. ShedlarzDirector2026-05-21A30,44100Derivative, Class A CommonForm 4 ↗
Sandra L. FenwickDirector2026-05-21A30,44100Derivative, Class A CommonForm 4 ↗
Kenneth H. PaulusDirector2026-05-21A30,44100Derivative, Class A CommonForm 4 ↗
David B. Snow, JrDirector2026-05-21A30,44100Derivative, Class A CommonForm 4 ↗
Catherine A. JacobsonDirector2026-05-21A30,44100Derivative, Class A CommonForm 4 ↗
Michael S. SmithDirector2026-05-21A30,44100Derivative, Class A CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-06-01A1,042——CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-06-01A9,152——CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-06-01A5,350——CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-06-01A426——CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-06-01D42600Derivative, Class A CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-06-01D83300Derivative, Class A CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-06-01D1,04200Derivative, Class A CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-06-01D5,49100Derivative, Class A CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-06-01D9,15200Derivative, Class A CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-06-01D4,85800Derivative, Class A CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-06-01D1,30000Derivative, Class A CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-06-01A4,858——CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-06-01A1,300——CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-06-01D3900Derivative, Class A CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-06-01A833——CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-06-01A39——CommonForm 4 ↗
Charles Divita, IIIDirector2026-06-01D42,27600Derivative, Class A CommonForm 4 ↗
Charles Divita, IIIDirector2026-06-01D1,96600Derivative, Class A CommonForm 4 ↗
Charles Divita, IIIDirector2026-06-01A42,276——CommonForm 4 ↗
Charles Divita, IIIDirector2026-06-01A1,966——CommonForm 4 ↗
Carlos NuenoPresident, International2026-06-01D8,71600Derivative, Class A CommonForm 4 ↗
Carlos NuenoPresident, International2026-06-01D4,55600Derivative, Class A CommonForm 4 ↗
Carlos NuenoPresident, International2026-06-01A8,716——CommonForm 4 ↗
Carlos NuenoPresident, International2026-06-01A4,556——CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-06-01D9,15200Derivative, Class A CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-06-01D5,35000Derivative, Class A CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-06-01A9,152——CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-06-01D8,71600Derivative, Class A CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-06-01A8,716——CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-06-01A5,491——CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-06-02D5,677843,298CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-06-02D7,679858,568CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-06-02D28482,166CommonForm 4 ↗
Charles Divita, IIIDirector2026-06-02D19,1328145,920CommonForm 4 ↗
Carlos NuenoPresident, International2026-06-02D6,196847,257CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-06-02D7,906860,299CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-06-03D9,572770,833CommonForm 4 ↗
Charles Divita, IIIDirector2026-06-10D39,16000Derivative, Class A CommonForm 4 ↗
Charles Divita, IIIDirector2026-06-10D3,64200Derivative, Class A CommonForm 4 ↗
Charles Divita, IIIDirector2026-06-10A39,160——CommonForm 4 ↗
Charles Divita, IIIDirector2026-06-10A3,642——CommonForm 4 ↗
Charles Divita, IIIDirector2026-06-11D18,0747125,470CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-06-29D2,500921,250CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-07-01D2,500922,500CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-07-01D2,08300Derivative, Class A CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-07-01A2,083——CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-07-02D65395,942CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-07-06D2,5001023,750CommonForm 4 ↗
Mark Anquillare VDirector2026-08-03A37,42500Derivative, Class A CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-09-01A5,350——CommonForm 4 ↗
Carlos NuenoPresident, International2026-09-01A4,556——CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-09-01D9,15200Derivative, Class A CommonForm 4 ↗
Carlos NuenoPresident, International2026-09-01D4,55600Derivative, Class A CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-09-01A8,717——CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-09-01A1,042——CommonForm 4 ↗
Charles Divita, IIIDirector2026-09-01D1,96600Derivative, Class A CommonForm 4 ↗
Charles Divita, IIIDirector2026-09-01A1,966——CommonForm 4 ↗
Charles Divita, IIIDirector2026-09-01A42,277——CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-09-01D3900Derivative, Class A CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-09-01A39——CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-09-01A833——CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-09-01D9,15200Derivative, Class A CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-09-01D8,71700Derivative, Class A CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-09-01D1,04200Derivative, Class A CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-09-01D5,49200Derivative, Class A CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-09-01A5,492——CommonForm 4 ↗
Charles Divita, IIIDirector2026-09-01D42,27700Derivative, Class A CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-09-01D83300Derivative, Class A CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-09-01D1,30000Derivative, Class A CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-09-01D4,85900Derivative, Class A CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-09-01A1,300——CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-09-01A9,152——CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-09-01A4,859——CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-09-01D42600Derivative, Class A CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-09-01D5,35000Derivative, Class A CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-09-01A426——CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-09-01A9,152——CommonForm 4 ↗
Carlos NuenoPresident, International2026-09-01D8,71700Derivative, Class A CommonForm 4 ↗
Carlos NuenoPresident, International2026-09-01A8,717——CommonForm 4 ↗
Michael F. GrasherChief Financial Officer2026-09-01A239,61600Derivative, Class A CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-09-02D27461,726CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-09-02D5,439634,271CommonForm 4 ↗
Charles Divita, IIIDirector2026-09-02D18,3276115,478CommonForm 4 ↗
Kelly BlissPresident, U.S. Group Health2026-09-02D7,357646,356CommonForm 4 ↗
Adam VandervoortCHIEF LEGAL OFFICER, SECRETARY2026-09-02D7,573647,717CommonForm 4 ↗
Carlos NuenoPresident, International2026-09-02D6,200639,066CommonForm 4 ↗
Fernando M. RodriguesPresident of BetterHelp2026-09-03D9,812763,876CommonForm 4 ↗
Charles Divita, IIIDirector2026-09-10A3,642——CommonForm 4 ↗
Charles Divita, IIIDirector2026-09-10D39,16000Derivative, Class A CommonForm 4 ↗
Charles Divita, IIIDirector2026-09-10D3,64200Derivative, Class A CommonForm 4 ↗
Charles Divita, IIIDirector2026-09-10A39,160——CommonForm 4 ↗
Charles Divita, IIIDirector2026-09-11D17,8056108,682CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-10-01D2,08300Derivative, Class A CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-10-01A2,083——CommonForm 4 ↗
Joseph Ronald CatapanoChief Accounting Officer2026-10-02D65563,703CommonForm 4 ↗
03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Mala MurthyRSU2025-03-01——172,594—$1,649,999
Adam VandervoortPSU2025-03-01—109,833—219,6661,050,003
Mala MurthyPSU2025-03-01—172,594—345,1881,649,999
Carlos NuenoPSU2025-03-01—104,603—209,2061,000,005
Kelly BlissRSU2025-03-01——109,832—1,049,994
Kelly BlissPSU2025-03-01—109,833—219,6661,050,003
Charles Divita, IIIPSU2025-03-01—507,322—1,014,6444,849,998
Adam VandervoortRSU2025-03-01——109,832—1,049,994
Charles Divita, IIIRSU2025-03-01——507,322—4,849,998
Carlos NuenoRSU2025-03-01——104,602—999,995
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Mala Murthy$1,649,999$1,649,999$050.0%
Adam Vandervoort1,049,9941,050,003050.0%
Carlos Nueno999,9951,000,005050.0%
Kelly Bliss1,049,9941,050,003050.0%
Charles Divita, III4,849,9984,849,998050.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Charles Divita, IIIRSU234,963—$1,644,741
Kelly BlissRSU82,375—576,625
Charles Divita, IIIRSU380,491—2,663,437
Adam VandervoortRSU82,375—576,625
Carlos NuenoRSU104,602—732,214
Kelly BlissRSU109,832—768,824
Carlos NuenoRSU104,603—732,221
Adam VandervoortRSU32,100—224,700
Kelly BlissRSU29,150—204,050
Carlos NuenoRSU3,101—21,707
Carlos NuenoRSU1,061—7,427
Charles Divita, IIIRSU704,887—4,934,209
Charles Divita, IIIRSU126,831—887,817
Carlos NuenoRSU22,782—159,474
Adam VandervoortRSU10,603—74,221
Kelly BlissRSU3,488—24,416
Carlos NuenoRSU7,440—52,080
Adam VandervoortRSU4,418—30,926
Kelly BlissRSU1,186—8,302
Kelly BlissRSU27,458—192,206
Carlos NuenoRSU27,337—191,359
Charles Divita, IIIRSU234,962—1,644,734
Charles Divita, IIIRSU507,322—3,551,254
Kelly BlissRSU8,371—58,597
Adam VandervoortRSU109,832—768,824
Adam VandervoortRSU26,750—187,250
Kelly BlissRSU24,293—170,051
Adam VandervoortRSU1,510—10,570
Adam VandervoortRSU27,458—192,206
05

Incentive-plan design — the Compensation Discussion & Analysis

Paying for performance is a key attribute of our compensation philosophy. Fundamentally, our executive compensation program links compensation to the achievement of specific, predetermined financial and performance goals that further our business strategies.

CEO STI target (% of salary)100%
CEO LTI target (% of salary)—
Independent consultantAon
Clawback policyTrue
Anti-hedgingTrue
Anti-pledgingTrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-05-2171,154,2688,973,2571,158,11688.8%Passed
20252025-05-2261,160,35522,179,678181,70273.39%Passed
20242024-05-2386,004,2163,679,987247,42695.9%Passed
20232023-05-2574,437,08016,406,746486,18081.94%Passed
20222022-05-2680,030,6747,339,906219,88291.6%Passed
20212021-05-1772,534,52010,671,743354,11987.17%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-05-2188.8%a
20252025-05-2273.39%b
20242024-05-2395.9%c

a. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect on any of the proposals included in this proxy statement.”.

b. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect on any of the proposals included in this proxy statement.”.

c. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect on any of the proposals included in this proxy statement.”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)127.6 : 1
CEO total compensation$11,202,996
Median employee compensation$87,811
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
David B. Snow, JrIndependent · Audit · Compensation$84,011$200,003$0$0$0$284,014
Kenneth H. PaulusIndependent · Board Chair · Nominating and Corporate Governance · Compensation · Executive83,489200,003000283,492
J. Eric EvansIndependent · Audit · Compensation (Chair) · Executive · Not standing for re-election75,000200,003000275,003
David L. ShedlarzIndependent · Audit (Chair) · Compensation72,500200,003000272,503
Thomas G. McKinleyIndependent · Audit · Compensation · Not standing for re-election62,500200,003000262,503
Mark Douglas Smith, M.D., MBAIndependent · Quality of Care and Patient Safety60,000200,003000260,003
Catherine A. JacobsonIndependent · Nominating and Corporate Governance (Chair) · Quality of Care and Patient Safety · Executive60,000200,003000260,003
Sandra L. FenwickIndependent · Compensation (Chair) · Quality of Care and Patient Safety · Executive55,000200,003000255,003
Susan R. SalkaIndependent · Audit · Partial-year service · Newly elected000000
Michael S. SmithIndependent · Audit · Partial-year service · Newly elected000000
Charles Divita, IIIEmployee director · Executive000—00
09

Board fee structure and ownership guideline

Annual cash retainer$45,000
Annual equity retainer$200,003
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)—
Stock ownership guideline$135,000
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$552,500
Equity awards (grant-date value)$1,600,024
All other compensation$0
Total cost of the board$2,152,524

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

10a

Peer reciprocity

Of the companies Teladoc Health names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Teladoc Health.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1DocuSign, Inc.2026Allan Thygesen$1,000,000$23,600,136$0$1,019,000$25,650,100
2Twilio Inc.2025Khozema Shipchandler1,100,00021,398,53901,507,00024,291,917
3Nutanix, Inc.2025Rajiv Ramaswami800,00020,750,88501,015,20022,569,085
4RingCentral, Inc.2024Vladimir Shmunis376,36714,565,1460533,31115,491,096
5Astrana Health, Inc.2025Brandon Sim850,00011,999,98002,059,12514,930,231
6Evolent Health, Inc.2025Seth Blackley867,06812,699,0860014,240,154
7Premier Inc.2024Michael Alkire1,095,8768,500,03901,800,15011,806,381
8Medpace, Inc.2025August Troendle937,41709,999,999011,443,766
9Alignment Healthcare, Inc.2025John Kao833,6548,500,01401,944,49511,278,583
10Maximus Inc.2025Bruce Caswell976,9236,862,17703,300,00011,210,668
11Teladoc Health2025Charles Divita, III800,0009,699,9960584,00011,202,996
12AMN Healthcare Services, Inc.2025Cary Grace1,060,0008,363,11701,146,12510,669,780
13Privia Health Group, Inc.2025Parth Mehrotra650,0008,588,37301,218,75010,472,698
14Agilon Health, Inc.2025Jeffrey Schwaneke625,0002,950,0031,750,000271,8755,610,878
15Aveanna Healthcare Holdings Inc.2025Jeffrey Shaner750,0002,603,99301,500,0004,864,165
16Euronet Worldwide, Inc.2025Michael Brown925,000001,850,0002,786,575
17Pediatrix Medical Group, Inc.2025James Swift54,167730,720068,9812,775,881
18Dropbox, Inc.2025Andrew Houston800,00000750,4002,166,622
19Clover Health Investments, Corp.2025Andrew Toy800,00000509,5391,319,385

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
Teladoc Health73%RSU 50 · PSU 50NoAon
Agilon Health, Inc.58%not disclosedNoSemler Brossy
Alignment Healthcare, Inc.200%not disclosedNoFW Cook
AMN Healthcare Services, Inc.87%not disclosedYes — Relative TSRFW Cook
Astrana Health, Inc.193.8%PSU 67 · RSU 33NoPearl Meyer
Aveanna Healthcare Holdings Inc.200%PSU 50 · RSU 50NoAon Human Capital Solutions (division of Aon plc)
Clover Health Investments, Corp.64%RSU 60 · Cash LTI 40NoAon, plc (Human Capital Practice)
DocuSign, Inc.101.9%PSU 60 · RSU 40Yes — TSRCompensia
Dropbox, Inc.107.3%RSU 100not disclosedCompensia
Euronet Worldwide, Inc.200%PRSU 100NoFW Cook
Evolent Health, Inc.75%PSU 70 · RSU 30NoExequity
Maximus Inc.220.0%PSU 100NoFW Cook
Medpace, Inc.52.5%Options 100not disclosedTotal Compensation Solutions (TCS)
Nutanix, Inc.126.9%RSU 50 · PSU 50Yes — Relative TSR vs Nasdaq Composite IndexCompensia, Inc.
Pediatrix Medical Group, Inc.180%PSU 50 · RSU 50NoSemler Brossy Consulting Group
Premier Inc.109.1%PSU 60 · RSU 40NoMercer
Privia Health Group, Inc.150%PSU 60 · RSU 40NoKorn Ferry (through September 2025), WTW (starting September 2025)
RingCentral, Inc.not disclosednot disclosedNoCompensia
Twilio Inc.137.0%PSU 60 · RSU 40YesCompensia

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

10d

Frequently asked questions

Who was the highest-paid executive at Teladoc Health in fiscal 2025?
As disclosed, Charles Divita, III (Chief Executive Officer) was the highest-paid executive at Teladoc Health in fiscal 2025, with total compensation of $11,202,996.
How does Teladoc Health's chief executive pay compare to its disclosed peer group?
As disclosed, Charles Divita, III's total compensation ranked at the 44th percentile of Teladoc Health's disclosed peer group.
What is Teladoc Health's CEO-to-median employee pay ratio?
As disclosed, Teladoc Health's CEO-to-median employee pay ratio was 127.6:1.
How did shareholders vote on Teladoc Health's executive compensation?
As disclosed, 88.8% of shareholders supported Teladoc Health's executive compensation in the latest say-on-pay vote.
How much does Teladoc Health spend in total on board compensation for fiscal 2025?
As disclosed, Teladoc Health reported total board compensation of $2,152,524 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Charles Divita, IIIDEF 14A2026-04-070001477449-26-000020Section “2025 Summary Compensation Table” · page 47. As printed: 11,202,996. Filing ↗machine: t167 · r2 · c16 · span 1057476–1057486
2Section 01, Mala MurthyDEF 14A2026-04-070001477449-26-000020Section “2025 Summary compensation table” · page 47. As printed: 3,803,373. Filing ↗machine: span 1066972–1066981
3Section 01, Carlos NuenoDEF 14A2026-04-070001477449-26-000020Section “2025 Summary compensation table” · page 47. As printed: 3,249,126. Filing ↗machine: span 1080611–1080620
4Section 01, Kelly BlissDEF 14A2026-04-070001477449-26-000020Section “2025 Summary compensation table” · page 47. As printed: 2,962,164. Filing ↗machine: span 1089869–1089878
5Section 01, Adam VandervoortDEF 14A2026-04-070001477449-26-000020Section “2025 Summary compensation table” · page 47. As printed: 2,855,997. Filing ↗machine: span 1099199–1099208
6Section 03, Mala Murthy RSUDEF 14A2026-04-070001477449-26-000020Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t160 · r3 · c1 · span 1019816–1019823
7Section 03, Adam Vandervoort PSUDEF 14A2026-04-070001477449-26-000020Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t171 · r15 · c10 · span 1170997–1171004
8Section 03, Mala Murthy PSUDEF 14A2026-04-070001477449-26-000020Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t160 · r3 · c1 · span 1019816–1019823
9Section 03, Carlos Nueno PSUDEF 14A2026-04-070001477449-26-000020Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t160 · r4 · c3 · span 1021372–1021379
10Section 03, Kelly Bliss RSUDEF 14A2026-04-070001477449-26-000020Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t160 · r5 · c1 · span 1022111–1022118
11Section 03, Kelly Bliss PSUDEF 14A2026-04-070001477449-26-000020Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t160 · r5 · c3 · span 1022519–1022526
12Section 03, Charles Divita, III PSUDEF 14A2026-04-070001477449-26-000020Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t171 · r3 · c17 · span 1133681–1133690
13Section 03, Adam Vandervoort RSUDEF 14A2026-04-070001477449-26-000020Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t171 · r16 · c11 · span 1174498–1174505
14Section 03, Charles Divita, III RSUDEF 14A2026-04-070001477449-26-000020Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t171 · r3 · c17 · span 1133681–1133690
15Section 03, Carlos Nueno RSUDEF 14A2026-04-070001477449-26-000020Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t160 · r4 · c1 · span 1020964–1020971
16Section 07, pay ratioDEF 14A2026-04-070001477449-26-000020Section “CEO Pay Ratio”. As printed: 127.6 : 1. Filing ↗machine: t197 · r3 · c1 · span 1416669–1416675
17Section 08, David B. Snow, JrDEF 14A2026-04-070001477449-26-000020Section “Director Compensation”. As printed: 284,014. Filing ↗machine: t97 · r9 · c5 · span 689974–690254
18Section 08, Kenneth H. PaulusDEF 14A2026-04-070001477449-26-000020Section “Director Compensation”. As printed: 283,492. Filing ↗machine: t97 · r6 · c5 · span 685802–686050
19Section 08, J. Eric EvansDEF 14A2026-04-070001477449-26-000020Section “Director Compensation”. As printed: 275,003. Filing ↗machine: t97 · r2 · c5 · span 680469–680715
20Section 08, David L. ShedlarzDEF 14A2026-04-070001477449-26-000020Section “Director Compensation”. As printed: 272,503. Filing ↗machine: t97 · r7 · c5 · span 687135–687383
21Section 08, Thomas G. McKinleyDEF 14A2026-04-070001477449-26-000020Section “Director Compensation”. As printed: 262,503. Filing ↗machine: t97 · r5 · c5 · span 684469–684717
22Section 08, Mark Douglas Smith, M.D., MBADEF 14A2026-04-070001477449-26-000020Section “Director Compensation”. As printed: 260,003. Filing ↗machine: t97 · r8 · c5 · span 688480–688728
23Section 08, Catherine A. JacobsonDEF 14A2026-04-070001477449-26-000020Section “Director Compensation”. As printed: 260,003. Filing ↗machine: t97 · r4 · c5 · span 683135–683383
24Section 08, Sandra L. FenwickDEF 14A2026-04-070001477449-26-000020Section “Director Compensation”. As printed: 255,003. Filing ↗machine: t97 · r3 · c5 · span 681798–682046
25Section 08, Susan R. SalkaDEF 14A2026-04-070001477449-26-000020Section “Director Compensation”. As printed: 0. Filing ↗
26Section 08, Michael S. SmithDEF 14A2026-04-070001477449-26-000020Section “Director Compensation”. As printed: 0. Filing ↗
27Section 08, Charles Divita, IIIDEF 14A2026-04-070001477449-26-000020Section “Director Compensation”. As printed: 0. Filing ↗
28Section 02, David B. Snow, Jr 2026-05-20Form 42026-05-210001203676-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
29Section 02, David B. Snow, Jr 2026-05-20Form 42026-05-210001203676-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
30Section 02, Catherine A. Jacobson 2026-05-20Form 42026-05-210001804442-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
31Section 02, Catherine A. Jacobson 2026-05-20Form 42026-05-210001804442-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
32Section 02, David L. Shedlarz 2026-05-20Form 42026-05-210001174459-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
33Section 02, David L. Shedlarz 2026-05-20Form 42026-05-210001174459-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
34Section 02, David L. Shedlarz 2026-05-21Form 42026-05-210001174459-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
35Section 02, Sandra L. Fenwick 2026-05-21Form 42026-05-210001302954-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
36Section 02, Kenneth H. Paulus 2026-05-21Form 42026-05-210001624004-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
37Section 02, David B. Snow, Jr 2026-05-21Form 42026-05-210001203676-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
38Section 02, Catherine A. Jacobson 2026-05-21Form 42026-05-210001804442-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
39Section 02, Michael S. Smith 2026-05-21Form 42026-05-210001756253-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
40Section 02, Fernando M. Rodrigues 2026-06-01Form 42026-06-030002037547-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
41Section 02, Kelly Bliss 2026-06-01Form 42026-06-030002036989-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
42Section 02, Adam Vandervoort 2026-06-01Form 42026-06-030001375088-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
43Section 02, Adam Vandervoort 2026-06-01Form 42026-06-030001375088-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Adam Vandervoort 2026-06-01Form 42026-06-030001375088-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
45Section 02, Joseph Ronald Catapano 2026-06-01Form 42026-06-030001714468-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
46Section 02, Fernando M. Rodrigues 2026-06-01Form 42026-06-030002037547-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
47Section 02, Fernando M. Rodrigues 2026-06-01Form 42026-06-030002037547-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
48Section 02, Kelly Bliss 2026-06-01Form 42026-06-030002036989-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
49Section 02, Kelly Bliss 2026-06-01Form 42026-06-030002036989-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
50Section 02, Kelly Bliss 2026-06-01Form 42026-06-030002036989-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
51Section 02, Kelly Bliss 2026-06-01Form 42026-06-030002036989-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
52Section 02, Kelly Bliss 2026-06-01Form 42026-06-030002036989-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
53Section 02, Joseph Ronald Catapano 2026-06-01Form 42026-06-030001714468-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
54Section 02, Joseph Ronald Catapano 2026-06-01Form 42026-06-030001714468-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
55Section 02, Joseph Ronald Catapano 2026-06-01Form 42026-06-030001714468-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
56Section 02, Charles Divita, III 2026-06-01Form 42026-06-030001347535-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
57Section 02, Charles Divita, III 2026-06-01Form 42026-06-030001347535-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
58Section 02, Charles Divita, III 2026-06-01Form 42026-06-030001347535-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
59Section 02, Charles Divita, III 2026-06-01Form 42026-06-030001347535-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
60Section 02, Carlos Nueno 2026-06-01Form 42026-06-030002037711-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
61Section 02, Carlos Nueno 2026-06-01Form 42026-06-030002037711-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
62Section 02, Carlos Nueno 2026-06-01Form 42026-06-030002037711-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
63Section 02, Carlos Nueno 2026-06-01Form 42026-06-030002037711-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
64Section 02, Adam Vandervoort 2026-06-01Form 42026-06-030001375088-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
65Section 02, Adam Vandervoort 2026-06-01Form 42026-06-030001375088-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
66Section 02, Adam Vandervoort 2026-06-01Form 42026-06-030001375088-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
67Section 02, Fernando M. Rodrigues 2026-06-01Form 42026-06-030002037547-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
68Section 02, Fernando M. Rodrigues 2026-06-01Form 42026-06-030002037547-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
69Section 02, Fernando M. Rodrigues 2026-06-01Form 42026-06-030002037547-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
70Section 02, Fernando M. Rodrigues 2026-06-02Form 42026-06-030002037547-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
71Section 02, Kelly Bliss 2026-06-02Form 42026-06-030002036989-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
72Section 02, Joseph Ronald Catapano 2026-06-02Form 42026-06-030001714468-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
73Section 02, Charles Divita, III 2026-06-02Form 42026-06-030001347535-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
74Section 02, Carlos Nueno 2026-06-02Form 42026-06-030002037711-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
75Section 02, Adam Vandervoort 2026-06-02Form 42026-06-030001375088-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
76Section 02, Fernando M. Rodrigues 2026-06-03Form 42026-06-040002037547-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
77Section 02, Charles Divita, III 2026-06-10Form 42026-06-120001347535-26-000007Insider equity transaction reported since the proxy statement. Filing ↗
78Section 02, Charles Divita, III 2026-06-10Form 42026-06-120001347535-26-000007Insider equity transaction reported since the proxy statement. Filing ↗
79Section 02, Charles Divita, III 2026-06-10Form 42026-06-120001347535-26-000007Insider equity transaction reported since the proxy statement. Filing ↗
80Section 02, Charles Divita, III 2026-06-10Form 42026-06-120001347535-26-000007Insider equity transaction reported since the proxy statement. Filing ↗
81Section 02, Charles Divita, III 2026-06-11Form 42026-06-120001347535-26-000007Insider equity transaction reported since the proxy statement. Filing ↗
82Section 02, Kelly Bliss 2026-06-29Form 42026-06-300002036989-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
83Section 02, Kelly Bliss 2026-07-01Form 42026-07-010002036989-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
84Section 02, Joseph Ronald Catapano 2026-07-01Form 42026-07-060001714468-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
85Section 02, Joseph Ronald Catapano 2026-07-01Form 42026-07-060001714468-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
86Section 02, Joseph Ronald Catapano 2026-07-02Form 42026-07-060001714468-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
87Section 02, Kelly Bliss 2026-07-06Form 42026-07-060002036989-26-000012Insider equity transaction reported since the proxy statement. Filing ↗
88Section 02, Mark Anquillare V 2026-08-03Form 42026-08-040001472710-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
89Section 02, Adam Vandervoort 2026-09-01Form 42026-09-030001375088-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
90Section 02, Carlos Nueno 2026-09-01Form 42026-09-030002037711-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
91Section 02, Kelly Bliss 2026-09-01Form 42026-09-030002036989-26-000014Insider equity transaction reported since the proxy statement. Filing ↗
92Section 02, Carlos Nueno 2026-09-01Form 42026-09-030002037711-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
93Section 02, Fernando M. Rodrigues 2026-09-01Form 42026-09-030002037547-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
94Section 02, Fernando M. Rodrigues 2026-09-01Form 42026-09-030002037547-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
95Section 02, Charles Divita, III 2026-09-01Form 42026-09-030001347535-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
96Section 02, Charles Divita, III 2026-09-01Form 42026-09-030001347535-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
97Section 02, Charles Divita, III 2026-09-01Form 42026-09-030001347535-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
98Section 02, Joseph Ronald Catapano 2026-09-01Form 42026-09-030001714468-26-000012Insider equity transaction reported since the proxy statement. Filing ↗
99Section 02, Joseph Ronald Catapano 2026-09-01Form 42026-09-030001714468-26-000012Insider equity transaction reported since the proxy statement. Filing ↗
100Section 02, Joseph Ronald Catapano 2026-09-01Form 42026-09-030001714468-26-000012Insider equity transaction reported since the proxy statement. Filing ↗
101Section 02, Adam Vandervoort 2026-09-01Form 42026-09-030001375088-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
102Section 02, Fernando M. Rodrigues 2026-09-01Form 42026-09-030002037547-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
103Section 02, Fernando M. Rodrigues 2026-09-01Form 42026-09-030002037547-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
104Section 02, Fernando M. Rodrigues 2026-09-01Form 42026-09-030002037547-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
105Section 02, Fernando M. Rodrigues 2026-09-01Form 42026-09-030002037547-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
106Section 02, Charles Divita, III 2026-09-01Form 42026-09-030001347535-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
107Section 02, Joseph Ronald Catapano 2026-09-01Form 42026-09-030001714468-26-000012Insider equity transaction reported since the proxy statement. Filing ↗
108Section 02, Kelly Bliss 2026-09-01Form 42026-09-030002036989-26-000014Insider equity transaction reported since the proxy statement. Filing ↗
109Section 02, Kelly Bliss 2026-09-01Form 42026-09-030002036989-26-000014Insider equity transaction reported since the proxy statement. Filing ↗
110Section 02, Kelly Bliss 2026-09-01Form 42026-09-030002036989-26-000014Insider equity transaction reported since the proxy statement. Filing ↗
111Section 02, Kelly Bliss 2026-09-01Form 42026-09-030002036989-26-000014Insider equity transaction reported since the proxy statement. Filing ↗
112Section 02, Kelly Bliss 2026-09-01Form 42026-09-030002036989-26-000014Insider equity transaction reported since the proxy statement. Filing ↗
113Section 02, Adam Vandervoort 2026-09-01Form 42026-09-030001375088-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
114Section 02, Adam Vandervoort 2026-09-01Form 42026-09-030001375088-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
115Section 02, Adam Vandervoort 2026-09-01Form 42026-09-030001375088-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
116Section 02, Adam Vandervoort 2026-09-01Form 42026-09-030001375088-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
117Section 02, Carlos Nueno 2026-09-01Form 42026-09-030002037711-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
118Section 02, Carlos Nueno 2026-09-01Form 42026-09-030002037711-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
119Section 02, Michael F. Grasher 2026-09-01Form 42026-09-010001575709-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
120Section 02, Joseph Ronald Catapano 2026-09-02Form 42026-09-030001714468-26-000012Insider equity transaction reported since the proxy statement. Filing ↗
121Section 02, Fernando M. Rodrigues 2026-09-02Form 42026-09-030002037547-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
122Section 02, Charles Divita, III 2026-09-02Form 42026-09-030001347535-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
123Section 02, Kelly Bliss 2026-09-02Form 42026-09-030002036989-26-000014Insider equity transaction reported since the proxy statement. Filing ↗
124Section 02, Adam Vandervoort 2026-09-02Form 42026-09-030001375088-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
125Section 02, Carlos Nueno 2026-09-02Form 42026-09-030002037711-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
126Section 02, Fernando M. Rodrigues 2026-09-03Form 42026-09-030002037547-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
127Section 02, Charles Divita, III 2026-09-10Form 42026-09-140001347535-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
128Section 02, Charles Divita, III 2026-09-10Form 42026-09-140001347535-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
129Section 02, Charles Divita, III 2026-09-10Form 42026-09-140001347535-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
130Section 02, Charles Divita, III 2026-09-10Form 42026-09-140001347535-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
131Section 02, Charles Divita, III 2026-09-11Form 42026-09-140001347535-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
132Section 02, Joseph Ronald Catapano 2026-10-01Form 42026-10-050001714468-26-000014Insider equity transaction reported since the proxy statement. Filing ↗
133Section 02, Joseph Ronald Catapano 2026-10-01Form 42026-10-050001714468-26-000014Insider equity transaction reported since the proxy statement. Filing ↗
134Section 02, Joseph Ronald Catapano 2026-10-02Form 42026-10-050001714468-26-000014Insider equity transaction reported since the proxy statement. Filing ↗
135Section 06, 2026 voteForm 8-K2026-05-210001477449-26-000030Item 5.07 · say-on-pay result. As reported: 88.8% (votes for as printed: 71,154,268). Filing ↗
136Section 06, 2025 voteForm 8-K2025-05-230001477449-25-000063Item 5.07 · say-on-pay result. As reported: 73.39% (votes for as printed: 61,160,355). Filing ↗
137Section 06, 2024 voteForm 8-K2024-05-240001477449-24-000122Item 5.07 · say-on-pay result. As reported: 95.9% (votes for as printed: 86,004,216). Filing ↗
138Section 01 trend, Δ column (computed)Computed——Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
139Section 03b vehicle mix (computed)Computed——RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
140Section 09b board cost (computed)Computed——Cash 552,500 + equity 1,600,024 + all other 0 = 2,152,524, summed across the director compensation table rows.machine: formula: Σ = 2,152,524
141DocuSign, Inc., Section 10b CEO totalDEF 14A2026-04-160001261333-26-000043CEO total compensation as printed in DocuSign, Inc.'s own proxy. As printed: 25,650,100. Filing ↗machine: r3 · c21 · span 792273–792283
142Twilio Inc., Section 10b CEO totalDEF 14A2026-04-280001140361-26-017444CEO total compensation as printed in Twilio Inc.'s own proxy. As printed: 24,291,917. Filing ↗machine: r2 · c19 · span 1822541–1822551
143Nutanix, Inc., Section 10b CEO totalDEF 14A2025-10-220001193125-25-246962CEO total compensation as printed in Nutanix, Inc.'s own proxy. As printed: 22,569,085. Filing ↗machine: r4 · c28 · span 1819325–1819335
144RingCentral, Inc., Section 10b CEO totalDEF 14A2025-12-090001384905-25-000059CEO total compensation as printed in RingCentral, Inc.'s own proxy. As printed: 15,491,096. Filing ↗machine: r2 · c42 · span 451975–451985
145Astrana Health, Inc., Section 10b CEO totalDEF 14A2026-04-170001104659-26-044536CEO total compensation as printed in Astrana Health, Inc.'s own proxy. As printed: 14,930,231. Filing ↗machine: span 525189–525199
146Evolent Health, Inc., Section 10b CEO totalDEF 14A2026-04-240001193125-26-177267CEO total compensation as printed in Evolent Health, Inc.'s own proxy. As printed: 14,240,154. Filing ↗machine: r3 · c20 · span 908544–908555
147Premier Inc., Section 10b CEO totalDEF 14A2024-10-210001193125-24-240399CEO total compensation as printed in Premier Inc.'s own proxy. As printed: 11,806,381. Filing ↗machine: span 1173351–1173361
148Medpace, Inc., Section 10b CEO totalDEF 14A2026-04-010001668397-26-000012CEO total compensation as printed in Medpace, Inc.'s own proxy. As printed: 11,443,766. Filing ↗machine: t43 · r3 · c9 · span 495770–495781
149Alignment Healthcare, Inc., Section 10b CEO totalDEF 14A2026-04-240001628280-26-027058CEO total compensation as printed in Alignment Healthcare, Inc.'s own proxy. As printed: 11,278,583. Filing ↗machine: r2 · c21 · span 656828–656838
150Maximus Inc., Section 10b CEO totalDEF 14A2026-01-220001032220-26-000007CEO total compensation as printed in Maximus Inc.'s own proxy. As printed: 11,210,668. Filing ↗machine: r3 · c24 · span 739406–739416
151Teladoc Health (subject), Section 10b CEO totalDEF 14A2026-04-070001477449-26-000020CEO total compensation as printed in Teladoc Health's own proxy. As printed: 11,202,996. Filing ↗machine: t167 · r2 · c16 · span 1057476–1057486
152AMN Healthcare Services, Inc., Section 10b CEO totalDEF 14A2026-03-180001104659-26-029908CEO total compensation as printed in AMN Healthcare Services, Inc.'s own proxy. As printed: 10,669,780. Filing ↗machine: t94 · r1 · c42 · span 1287064–1287074
153Privia Health Group, Inc., Section 10b CEO totalDEF 14A2026-04-020001193125-26-138997CEO total compensation as printed in Privia Health Group, Inc.'s own proxy. As printed: 10,472,698. Filing ↗machine: t166 · r3 · c39 · span 538905–538915
154Agilon Health, Inc., Section 10b CEO totalDEF 14A2026-04-220001628280-26-026544CEO total compensation as printed in Agilon Health, Inc.'s own proxy. As printed: 5,610,878. Filing ↗machine: r5 · c9 · span 1591317–1591326
155Aveanna Healthcare Holdings Inc., Section 10b CEO totalDEF 14A2026-04-170001193125-26-161632CEO total compensation as printed in Aveanna Healthcare Holdings Inc.'s own proxy. As printed: 4,864,165. Filing ↗machine: r3 · c31 · span 437702–437711
156Euronet Worldwide, Inc., Section 10b CEO totalDEF 14A2026-04-130001554855-26-000595CEO total compensation as printed in Euronet Worldwide, Inc.'s own proxy. As printed: 2,786,575. Filing ↗machine: span 581086–581095
157Pediatrix Medical Group, Inc., Section 10b CEO totalDEF 14A2026-03-270001193125-26-127299CEO total compensation as printed in Pediatrix Medical Group, Inc.'s own proxy. As printed: 2,775,881. Filing ↗machine: r22 · c24 · span 1960691–1960700
158Dropbox, Inc., Section 10b CEO totalDEF 14A2026-04-070001467623-26-000020CEO total compensation as printed in Dropbox, Inc.'s own proxy. As printed: 2,166,622. Filing ↗machine: span 785543–785552
159Clover Health Investments, Corp., Section 10b CEO totalDEF 14A2026-04-280001801170-26-000102CEO total compensation as printed in Clover Health Investments, Corp.'s own proxy. As printed: 1,319,385. Filing ↗machine: t30 · r2 · c22 · span 493279–493288
160Section 10a, Evolent Health, Inc. reciprocityDEF 14A—0001193125-26-177267Evolent Health, Inc. names Teladoc Health in its own disclosed peer group (read from its most recent proxy). Filing ↗
161Section 10a, AMN Healthcare Services, Inc. reciprocityDEF 14A—0001104659-26-029908AMN Healthcare Services, Inc. names Teladoc Health in its own disclosed peer group (read from its most recent proxy). Filing ↗
162Section 10a, Clover Health Investments, Corp. reciprocityDEF 14A—0001801170-26-000102Clover Health Investments, Corp.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health. Filing ↗
163Section 10a, DocuSign, Inc. reciprocityDEF 14A—0001261333-26-000043DocuSign, Inc.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health. Filing ↗
164Section 10a, Medpace, Inc. reciprocityDEF 14A—0001668397-26-000012Medpace, Inc.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health. Filing ↗
165Section 10a, Nutanix, Inc. reciprocityDEF 14A—0001193125-25-246962Nutanix, Inc.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health. Filing ↗
166Section 10a, Premier Inc. reciprocityDEF 14A—0001193125-24-240399Premier Inc.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health. Filing ↗
167Section 10a, RingCentral, Inc. reciprocityDEF 14A—0001384905-25-000059RingCentral, Inc.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health. Filing ↗
168Section 10a, Twilio Inc. reciprocityDEF 14A—0001140361-26-017444Twilio Inc.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health. Filing ↗
169Section 10a, Agilon Health, Inc. reciprocityDEF 14A—0001628280-26-026544Agilon Health, Inc. names Teladoc Health in its own disclosed peer group (read from its most recent proxy). Filing ↗
170Section 10a, Alignment Healthcare, Inc. reciprocityDEF 14A—0001628280-26-027058Alignment Healthcare, Inc. names Teladoc Health in its own disclosed peer group (read from its most recent proxy). Filing ↗
171Section 10a, Aveanna Healthcare Holdings Inc. reciprocityDEF 14A—0001193125-26-161632Aveanna Healthcare Holdings Inc.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health. Filing ↗
172Section 10a, Dropbox, Inc. reciprocityDEF 14A—0001467623-26-000020Dropbox, Inc.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health. Filing ↗
173Section 10a, Maximus Inc. reciprocityDEF 14A—0001032220-26-000007Maximus Inc.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health. Filing ↗
174Section 10a, Privia Health Group, Inc. reciprocityDEF 14A—0001193125-26-138997Privia Health Group, Inc. names Teladoc Health in its own disclosed peer group (read from its most recent proxy). Filing ↗

The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.

You'll confirm on The Pay Desk's sign-up page.